Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro

Journal of Neural Transmission

Volumn 114, Issue 9, 2007, Pages 1143-1146

  Lahti, R A ^a   Tamminga, C A ^b   Carlsson, A ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dopamine; GTPgammaS35; Partial dopamine agonist; Psychosis

Indexed keywords

3 [3 (METHYLSULFONYL)PHENYL] 1 PROPYLPIPERIDINE; DOPAMINE 2 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); PIPERIDINES; RECEPTORS, DOPAMINE D2;

EID: 34548181763     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0784-7     Document Type: Article

References (12)

1. A Carlsson ML Carlsson 2006 A dopaminergic deficit hypothesis of schizophrenia: the path to discovery Dialog Clin Neurosci 8 1 137 142
2. ML Carlsson A Carlsson M Nilsson 2004 Schizophrenia: from dopamine to glutamate and back Curr Med Chem 11 3 267 277
3. 2l receptors Neuropsychopharmacology 27 5 723 726
4. Gefvert O, Lindström L, Dahlbäck O, Sonesson C, Waters N (2000) (-)-OSU6162 induces a rapid onset of antipsychotic effect after a single dose. A double-blind placebo-controlled study. Nord J Psychiatry pp 93-94. Abstract
5. 2 short isoform in dopaminergic pathways Proc Natl Acad Sci USA 95 13 7731 7736
6. 2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities Mol Pharmacol 42 3 432 438
7. 2 receptors in rat striatal and mesolimbic tissues, using [125I] 2′-iodospiperone Psychopharmacology (Berl) 110 1-2 27 36
8. 3 receptors Mol Pharmacol 43 5 749 754
9. 2 receptor occupancy, antipsychotic-like efficacy and low potential for motor side effects in the rat J Pharmacol Exp Ther 318 2 810 818
10. H Neu P Hartvig R Torstenson KJ Fasth C Sonesson N Waters A Carlsson J Tedroff B Langstrom 1997 Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography Nucl Med Biol 24 6 507 511
11. P Seeman H-C Guan 2007 Dopamine partial agonist action of (-)-OSU6162 is consistent with dopamine hyperactivity in psychosis Eur J Pharmacol 557 2-3 151 153
12. C Sonesson CH Lin L Hansson N Waters K Svensson A Carlsson MW Smith H Wikstrom 1994 Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships J Med Chem 37 17 2735 2753